As research continues to advance, its clear that transdermal therapies, especially when compounded with innovative vehicles like Pentravan, have the potential to dramatically improve the quality of life for patients
If the patient experiences side effects, the dosage escalation is delayed for 4 weeks
Compared to classical gastroprotective peptides such as sucralfate or proton pump inhibitors (PPIs), it acts via a completely different pathway: restoration of mucosal microcirculation rather than acid reduction or formation of a mechanical protective layer
[DOI] [PubMed] [Google Scholar] 240.Heinrich P.C., Behrmann I., Haan S., Hermanns H.M., Mller-Newen G., Schaper F
The mechanism is consistent with general lymphoid tissue growth under elevated IGF-1 exposure
Malaisrie SC, Hofstetter WL, Correa AM, Ajani JA, Komaki RR, Rice DC, Vaporciyan AA, Walsh GL, Roth JA, SG||B |